2m 2m 2m 2m 2m 2m 2m
VYNE THERAP (VYNE)
NASDAQ
$0.66+$0.001 (+0.17%)
Price as of Jul 13, 2026 7:59 PM EDT- $21.3MMarket Cap
- -50.53%1-Year Change
- BiotechnologyIndustry
VYNE THERAP (VYNE)
$0.66+$0.001 (+0.17%)
VYNE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.66 | ||
Change | +$0.02 (+3.18%) | ||
Open | $0.64 | ||
High | $0.69 | ||
Low | $0.64 | ||
Previous Close | $0.64 | ||
Volume | 2,952,001 | ||
30-Day Average Volume | 1,160,122 | ||
1-Week Change | -1.45% | ||
1-Month Change | 1.45% | ||
1-Year Change | -50.53% | ||
3-Year Change | -83.95% | ||
5-Year Change | -98.77% | ||
Fundamentals | |||
Shares Outstanding | 33.4M | ||
Total Assets | $25.9M | ||
Market Cap | $21.3M | ||
Enterprise Value | -$3.3M | ||
Period: QTR TTM FY | |||
Revenue | $86,000.00 | ||
Net Income | -$3.6M | ||
Free Cash Flow | -$4.1M | ||
EBIT | -$3.6M | ||
EBITDA | -$3.6M | ||
Net Working Capital | N/A | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | -39 | ||
P/B | 1 | ||
P/E | -8 | ||
PEG | -0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 07/22/2026 | ||
Last Split Factor | 1 : 18 | ||
Last Split Date | 02/13/2023 | ||
Earnings & Revenue